These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3238650)

  • 21. Fibrinogen Milano V: a congenital dysfibrinogenaemia with a gamma 275 Arg-->Cys substitution.
    Steinmann C; Bögli C; Jungo M; Lämmle B; Heinemann G; Wermuth B; Redaelli R; Baudo F; Furlan M
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):463-71. PubMed ID: 7841300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid identification of comigrating gel-isolated proteins by ion trap-mass spectrometry.
    Arnott D; Henzel WJ; Stults JT
    Electrophoresis; 1998 May; 19(6):968-80. PubMed ID: 9638943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin.
    Lindo VS; Kakkar VV; Learmonth M; Melissari E; Zappacosta F; Panico M; Morris HR
    Br J Haematol; 1995 Mar; 89(3):589-601. PubMed ID: 7734359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-Glycosylation of pig flavin-containing monooxygenase form 1: determination of the site of protein modification by mass spectrometry.
    Korsmeyer KK; Guan S; Yang ZC; Falick AM; Ziegler DM; Cashman JR
    Chem Res Toxicol; 1998 Oct; 11(10):1145-53. PubMed ID: 9778310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of cysteinylation of pharmaceutical-grade human serum albumin by electrospray ionization mass spectrometry and low-energy collision-induced dissociation tandem mass spectrometry.
    Kleinova M; Belgacem O; Pock K; Rizzi A; Buchacher A; Allmaier G
    Rapid Commun Mass Spectrom; 2005; 19(20):2965-73. PubMed ID: 16178042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous variant of antithrombin III: AT III Fontainebleau.
    Boyer C; Wolf M; Vedrenne J; Meyer D; Larrieu MJ
    Thromb Haemost; 1986 Aug; 56(1):18-22. PubMed ID: 3775688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A determination of the positions of disulphide bonds in Paim I, alpha-amylase inhibitor from Streptomyces corchorushii, using fast atom bombardment mass spectrometry.
    Akashi S; Hirayama K; Seino T; Ozawa S; Fukuhara K; Oouchi N; Murai A; Arai M; Murao S; Tanaka K
    Biomed Environ Mass Spectrom; 1988 May; 15(10):541-6. PubMed ID: 3261606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mass determination of plasma-derived glycoproteins by ultraviolet matrix-assisted laser desorption/ionization time-of-flight mass spectrometry with internal calibration.
    Belgacem O; Buchacher A; Pock K; Josic D; Sutton C; Rizzi A; Allmaier G
    J Mass Spectrom; 2002 Nov; 37(11):1118-30. PubMed ID: 12447888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability.
    Koide T; Odani S; Takahashi K; Ono T; Sakuragawa N
    Proc Natl Acad Sci U S A; 1984 Jan; 81(2):289-93. PubMed ID: 6582486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin-III Denver, a reactive site variant.
    Stephens AW; Thalley BS; Hirs CH
    J Biol Chem; 1987 Jan; 262(3):1044-8. PubMed ID: 3805013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An analogy between fetal haptoglobin and a potent immunosuppressant in cancer.
    Oh SK; Very DL; Walker J; Raam S; Ju ST
    Cancer Res; 1987 Oct; 47(19):5120-6. PubMed ID: 3621198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antithrombin III Alger: a new homozygous AT III variant.
    Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
    Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptic peptide mapping of sequence 1-298 of human serum albumin by high-performance liquid chromatography and fast-atom bombardment mass spectrometry.
    Compagnini A; Fisichella S; Foti S; Saletti R; Sardo L
    Rapid Commun Mass Spectrom; 1994 Jun; 8(6):459-64. PubMed ID: 8043915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombin III Basel. Identification of a Pro-Leu substitution in a hereditary abnormal antithrombin with impaired heparin cofactor activity.
    Chang JY; Tran TH
    J Biol Chem; 1986 Jan; 261(3):1174-6. PubMed ID: 3080419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The covalent nature of the human antithrombin III--thrombin bond.
    Longas MO; Finlay TH
    Biochem J; 1980 Sep; 189(3):481-9. PubMed ID: 7213342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Location of disulfide bonds in antithrombin III.
    Zhou ZR; Smith DL
    Biomed Environ Mass Spectrom; 1990 Dec; 19(12):782-6. PubMed ID: 2088576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of the second alpha-2-antiprotease of equine serum as antithrombin III.
    Pellegrini A; Zweifel HR; von Fellenberg R
    Int J Biochem; 1983; 15(7):917-22. PubMed ID: 6884568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional antithrombin-III variant (41 Pro----Leu) identified by liquid secondary ion mass spectrometry.
    Brennan SO; Borg JY; Shaw GJ; Caen J; George PM
    Pathology; 1991 Jan; 23(1):1-4. PubMed ID: 2062560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of the antithrombin III tours deficiency.
    Duchange N; Chasse JF; Cohen GN; Zakin MM
    Thromb Res; 1987 Jan; 45(1):115-21. PubMed ID: 3563974
    [No Abstract]   [Full Text] [Related]  

  • 40. Abnormal reactivity with thrombin of a new variant of dysfunctional antithrombin (AT 'Vicenza').
    Finazzi G; Barbui T; Tran TH; Duckert F
    Ric Clin Lab; 1984; 14(3):515-9. PubMed ID: 6522961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.